CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.
about
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's diseaseDecreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulationStriatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.Activated microglia proliferate at neurites of mutant huntingtin-expressing neuronsBasal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.Huntington's disease, calcium, and mitochondria.Ras guanyl nucleotide releasing protein 2 affects cell viability and cell-matrix adhesion in ECV304 endothelial cells.Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements.Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract.Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease.Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay.Development of repetitive behavior in a mouse model: roles of indirect and striosomal basal ganglia pathways.Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
P2860
Q27011417-A109B70C-FEBD-472F-A2EC-7779EB99632EQ28479035-4EB1C0AA-58B2-4AF6-BC7A-E8608411B316Q33831774-82702DEB-AF41-4E71-98E3-D69994499506Q34159126-CBC641EA-2599-4AA4-8127-D806CBB8C152Q35103285-40235A41-015A-4823-9DF8-8BB151CAFF86Q35208420-6D8B9D09-9AE1-4C61-979B-30DC52F1A751Q37889820-21B111C7-461F-4261-B954-65EB5077F872Q39170092-D815144B-39D2-4BB2-A930-650A6BEB0204Q41701052-4748F421-A0BD-4416-969B-DDD7FFCB2552Q42267466-9124E951-10C9-4701-8991-B9184AA032C9Q42701855-6AC4E749-6201-46DA-B8DB-2876E9502BD8Q42741104-1EB676D4-8132-4BD7-B98D-8ECC263595EEQ42744117-12862AC7-10BF-44AC-8463-90EE921161CFQ58700269-54A5DFFF-D032-48DC-88D1-B3C0A78B265F
P2860
CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@ast
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@en
type
label
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@ast
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@en
prefLabel
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@ast
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@en
P2093
P2860
P356
P1476
CalDAG-GEFI down-regulation in ...... hange in Huntington's disease.
@en
P2093
Ann M Graybiel
Anna E Borkowska
Ben Woodman
David E Housman
Denise E Dunn
Donald C Lo
Jill R Crittenden
Matthew P Frosch
Michael Yim
P2860
P304
P356
10.1093/HMG/DDQ055
P577
2010-02-10T00:00:00Z